95 results on '"Connors, Lawreen H."'
Search Results
2. Design and Rationale the SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study
3. Role of Complementarity-Determining Regions 1 and 3 in Pathologic Amyloid Formation by Human Immunoglobulin κ1 Light Chains
4. An additive destabilising effect of compound T60I and V122I substitutions in ATTRv amyloidosis
5. Mapping Cellular Response to Destabilized Transthyretin Reveals Cell- and Amyloidogenic Protein-Specific Signatures
6. A novel substitution of proline (P32L) destabilises β2-microglobulin inducing hereditary systemic amyloidosis
7. Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays
8. A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation
9. Bone Marrow Biopsy and Its Utility in the Diagnosis of AL Amyloidosis
10. A 40-Year Natural History Study of Overall Survival and Primary Causes of Death in Systemic Light Chain (AL) Amyloidosis
11. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study
12. Bone Marrow Biopsy and Its Utility in the Diagnosis of AL Amyloidosis and Other Plasma Cell Dyscrasias
13. Abstract 15242: Increased Mortality Among African American Patients With Heart Failure Caused by Hereditary Transthyretin Amyloid Cardiomyopathy
14. Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities
15. Racial and Ethnic Disparities in Systemic AL Amyloidosis: Examining Differences in Clinical Presentation and Outcomes
16. Glycosylation of Serum Clusterin in Wild-Type Transthyretin-Associated (ATTRwt) Amyloidosis: A Study of Disease-Associated Compositional Features Using Mass Spectrometry Analyses
17. Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis
18. Expression of Amyloidogenic Transthyretin Drives Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid Disease
19. Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis
20. Structural Characterization of Cardiac Ex Vivo Transthyretin Amyloid: Insight into the Transthyretin Misfolding Pathway In Vivo
21. Human Amyloidogenic Light Chains Directly Invoke Oxidant Stress and Result in Impaired Cardiomyocyte Function
22. A new era of amyloidosis: the trends at a major US referral centre
23. Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis
24. Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
25. Effect of diflunisal on clusterin levels in ATTRwt amyloidosis
26. Structural studies of serum clusterin in ATTRwt amyloidosis
27. The Changing Face of Amyloidosis Referrals at a Tertiary Center over the Past 3 Decades
28. A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics
29. Amyloidogenic Proteins Drive Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid Disease
30. Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease
31. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience
32. Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin
33. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR)
34. Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant
35. Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure
36. Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm)
37. Oxidative post-translational modifications of an amyloidogenic immunoglobulin light chain protein
38. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis
39. Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis
40. Familial wild-type transthyretin cardiomyopathy
41. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model
42. Blood Proteomic Profiling in Inherited (ATTRm) and Acquired (ATTRwt) Forms of Transthyretin-Associated Cardiac Amyloidosis
43. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio
44. Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin
45. Abstract 16542: Predictors of Mortality in Patients With Light Chain (AL) Amyloidosis Heart Failure: A Multi-variate Analysis
46. Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literature
47. Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain‐mediated cardiotoxicity
48. Characterization of betabellins 15D and 16D, designed beta-sandwich proteins that have amyloidogenic properties
49. Cooperative Stabilization of Transthyretin by Clusterin and Diflunisal
50. Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.